Concepedia

Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice

Lisa Polin, Frederick A. Valeriote, Kathryn White, Chiab Panchapor, Susan Pugh, Juiwanna Knight, Patricia LoRusso, Maha Hussain, Elaine Liversidge, Nancy Peltier,

Investigational New Drugs · 1997 · 48 citations · 6 references

DOI

Concepts

References

6

Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the eastern cooperative oncology group

B J Roth, Patrick J. Loehrer, Beow Y. Yeap et al. · Cancer · 1993 · 161 citations · Full text

, , +12

Establishment of a New Prostatic Carcinoma Cell Line (TSU-PR1)

Tatsuo Iizumi, Tsunetada Yazaki, Shori Kanoh et al. · The Journal of Urology · 1987 · 148 citations

, , +15

Toxicity and anticancer activity of a new triazine antifolate (NSC 127755).

Thomas H. Corbett, Wilbur R. Leopold, Donald J. Dykes et al. · PubMed · 1982 · 71 citations

, , +10

Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents.

Corbett Th, Roberts Bj, Trader Mw et al. · PubMed · 1982 · 44 citations

, , +8

Preclinical anticancer activity of cryptophycin-8.

T. H. CORBETT, Fred Valeriote, Lisa Demchik et al. · PubMed · 1996 · 39 citations

, , +10